(Q46235539)

20 December 2017

title

Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy (English)

1 reference

20 December 2017

1 reference

Kozo Ohkusu-Tsukada

1

1 reference

20 December 2017

Masahiro Toda

2

1 reference

20 December 2017

Heiichiro Udono

3

1 reference

20 December 2017

Yutaka Kawakami

4

1 reference

20 December 2017

Kimimasa Takahashi

5

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

20 December 2017

European Journal of Immunology

published in

1 reference

20 December 2017

volume

40

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

1011-1021

1 reference

20 December 2017

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Natural versus adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Making and circumventing tolerance to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Regulatory T cells and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Sequential Involvement of Two Distinct CD4+ Regulatory T Cells during the Course of Transplantable Tumor Growth and Protection from 3–Methylcholanthrene‐induced Tumorigenesis by CD25–depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Regulation of the maintenance of peripheral T-cell anergy by TAB1-1 mediated p38alpha activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

DLGH1 is a negative regulator of T-lymphocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but not NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

Inducing and expanding regulatory T cell populations by foreign antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

7 January 2021

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

7 January 2021

High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

7 January 2021

IL-10 or not IL-10: that is the question

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

7 January 2021

Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

7 January 2021

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939513

7 January 2021

Identifiers

DOI

10.1002/EJI.200939513

1 reference

20 December 2017

PubMed ID

20127675

1 reference

20 December 2017